NASDAQ: ILMN

Illumina Recognized As #20 on Fortune's Change the World List

Multimedia with summary

Each year, Fortune Magazine publishes their Change The World list to celebrate companies and leaders that embrace corporate purpose and have had a positive social impact. We are humbled to be recognized at number 20 on the list as a company with measurable social impact, business results, and innovation.

Illumina Launches New Employee Resource Group iLatinx During Hispanic Heritage Month

Blog

At Illumina, we are committed to fostering a diverse, inclusive environment. One of the many ways we celebrate our employees’ unique life experiences, talents, and passions is through employee resource groups (ERGs). During Hispanic Heritage Month, we launched our newest employee resource group, iLatinx. iLatinx will support Latinx-identified employees by creating forums to discuss Latinx cultures and issues, to educate others throughout the organization, and provide leadership development opportunities for Latinx employees.

Illumina Commits to 100 Percent Clean, Renewable Energy from San Diego Community Power

Leading developer of life science tools joins an innovative group of Power100 Champions, leading the region to a sustainable future
Press Release

SAN DIEGO, October 18, 2021 /3BL Media/ – San Diego Community Power (SDCP), the not-for-profit community choice energy program, today announced Illumina’s (NASDAQ: ILMN) decision to opt-up to SDCP’s Power100 service tier. SDCP will provide all current San Diego-based Illumina facilities with 100% renewable, 100% carbon-free electricity, further cementing the company’s leadership in environmental stewardship for the life sciences industry.

"Pharmacogenomics Saved My Life"

Idaho mother and mental health advocate Mehri Coulter says PGx testing helped her get healthy
Article

“My family won the genetic bipolar lottery,” says Mehri Coulter, 36, of Boise, Idaho. “My great-grandma, grandma, mom, sister, and nephew had or have bipolar.”

San Diego Squared Announces 2021 STEM Educators Awards Recipients

Press Release

SAN DIEGO, October 5, 2021 /3BL Media/ - San Diego Squared, a local nonprofit, announced the four winners of the $5,000 SD2 STEM Educators Awards, powered by the Illumina Corporate Foundation and Neurocrine Biosciences.

The Illumina Corporate Foundation SD2 STEM Educators Award recipients are Liann Page from the School of Creative and Performing Arts and Kim Morris from Morse High School. The Neurocrine Biosciences SD2 STEM Educators Award recipients are Adan Escobedo from Granger High School and Khamphet Pease from Wilson Middle School.

Illumina's Sustainability Efforts Rewarded With Gold Rating From EcoVadis

Article

Illumina has been awarded the EcoVadis Gold Star Rating for sustainability efforts, which places Illumina among the top 5% globally for sustainability performance and the top 2% in our industry out of the 75,000 companies assessed across 160 countries and 200 industries.

EcoVadis is a ratings platform that assesses a company’s sustainability based on 21 criteria across four main topic areas of environment, labor and human rights, fair business practices and sustainable procurement.

SBTi Validates and Approves Illumina's Climate Action Targets

Article

It is official! The Science Based Targets Initiative (SBTi) has independently validated and approved Illumina’s climate action GHG emissions reduction targets. Approving our targets indicates they have been confirmed to be consistent with the reductions required to keep warming to 1.5°C, the most ambitious goal of the Paris Agreement and most ambitious designation available through the SBTi verification process.

On World Cancer Research Day, Illumina Highlights the Transformative Power of Genomics

On World Cancer Research Day, two experts share their enthusiasm for the potential of genomic and multiomic data to transform oncology
Article

Cancer is a devastating disease that is quickly becoming the leading cause of death worldwide. In 2020, there were nearly 10 million cancer deaths around the globe.

Illumina's Spotlight on Ovarian Cancer: Understanding Tumors Through Comprehensive Genomic Profiling

When it comes to cancer, knowledge is power—and sequencing brought answers for one California couple
Article

“Growing up, I had a fear of being broadsided. The idea of an out-of-nowhere collision that might kill or maim me was terrifying. I grew out of this fear and while I’ve never been in that kind of accident, I have been repeatedly broadsided by cancer for the past 11 years.”

Illumina Ventures Closes $325 Million Fund Supporting Start-ups in Healthcare Innovation

Genomics-Focused Fund Will Support Start-Ups in Healthcare Innovation
Article

San Francisco, September 29, 2021 /3BL Media/ – Illumina Ventures, an independently-managed, healthcare-focused venture firm, announced today the closing of its second investment fund with total commitments of $325 million, bringing its total capital under management to $560 million. The latest fund is anchored by Illumina, Inc. (Nasdaq: ILMN), with the majority of the total committed capital from other strategic and financial investors, including the Ireland Strategic Investment Fund (ISIF).

Pages

Subscribe to NASDAQ: ILMN